Neuroprotective effects of zafirlukast, piracetam and their combination on L-Methionine-induced vascular dementia in rats
- PMID: 31001898
- DOI: 10.1111/fcp.12473
Neuroprotective effects of zafirlukast, piracetam and their combination on L-Methionine-induced vascular dementia in rats
Abstract
Vascular dementia is considered a vascular cognitive impairment disease caused by neuronal degeneration in the brain. Several studies have supported the hypothesis that oxidative stress and endothelial dysfunction are the main pathogenic factors in vascular dementia. This current study aims to determine the possible neuroprotective effects of zafirlukast, piracetam and the combination of piracetam and zafirlukast on L-methionine-induced vascular dementia in rats. Male Wistar albino rats were divided into five groups. Group I was the normal control, and group II received L-methionine (1700 mg/kg, P.O.) for 32 days. The remaining groups received zafirlukast (20 mg/kg, P.O.), piracetam (600 mg/kg, P.O.) or their combination (zafirlukast 20 mg/kg + piracetam 600 mg/kg, P.O.) for 32 days after L-methionine administration. Afterwards, the cognitive and memory performances of the rats were investigated using the novel object recognition (NOR) test; rats were then sacrificed for histopathological and biochemical analyses. L-methionine-induced vascular dementia altered rats' behaviours and the brain contents of different neurotransmitters and acetylcholinesterase activity while increasing levels of oxidative stress and causing notable histopathological alterations in brain tissues. The treatment of vascular dementia with zafirlukast and the combination improved neurochemical, behavioural and histological alterations to a comparable level to those of piracetam. Thus, zafirlukast, piracetam and the combination of both drugs can be considered as potential therapeutic strategies for the treatment of vascular dementia induced by L-methionine. To the best of our knowledge, this study is the first to explore the neuroprotective effects of zafirlukast and piracetam on L-methionine-induced vascular dementia.
Keywords: L-methionine; acetylcholine; amyloid beta; brain; piracetam; vascular dementia; zafirlukast.
© 2019 Société Française de Pharmacologie et de Thérapeutique.
Similar articles
-
Neuroprotective Effects of Simvastatin and Cilostazol in L-Methionine-Induced Vascular Dementia in Rats.Mol Neurobiol. 2017 Sep;54(7):5074-5084. doi: 10.1007/s12035-016-0051-8. Epub 2016 Aug 20. Mol Neurobiol. 2017. PMID: 27544235
-
Possible role of endothelin receptor against hyperhomocysteinemia and β-amyloid induced AD type of vascular dementia in rats.Brain Res Bull. 2017 Jul;133:31-41. doi: 10.1016/j.brainresbull.2017.02.012. Epub 2017 Mar 6. Brain Res Bull. 2017. PMID: 28274813
-
Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced vascular dementia.Int J Neurosci. 2022 Apr;132(4):384-396. doi: 10.1080/00207454.2020.1817009. Epub 2020 Sep 11. Int J Neurosci. 2022. PMID: 32859137
-
The mechanistic role of piracetam in the management of vascular dementia.Behav Brain Res. 2025 May 28;486:115551. doi: 10.1016/j.bbr.2025.115551. Epub 2025 Mar 24. Behav Brain Res. 2025. PMID: 40139397 Review.
-
"Brain-specific" nutrients: a memory cure?Nutrition. 2003 Nov-Dec;19(11-12):957-75. doi: 10.1016/s0899-9007(03)00024-8. Nutrition. 2003. PMID: 14624946 Review.
Cited by
-
Piracetam as Neuroprotective, Anticonvulsant, and Anti-Anxiety Agent: An In Vivo Study on Ptz Epileptic Rats.Arch Razi Inst. 2024 Oct 31;79(5):1057-1064. doi: 10.32592/ARI.2024.79.5.1057. eCollection 2024 Oct. Arch Razi Inst. 2024. PMID: 40292057 Free PMC article.
-
Neuroprotective effect of piracetam-loaded magnetic chitosan nanoparticles against thiacloprid-induced neurotoxicity in albino rats.Inflammopharmacology. 2023 Apr;31(2):943-965. doi: 10.1007/s10787-023-01151-x. Epub 2023 Feb 6. Inflammopharmacology. 2023. PMID: 36745244 Free PMC article.
-
Sitagliptin Attenuates the Cognitive Deficits in L-Methionine-Induced Vascular Dementia in Rats.Biomed Res Int. 2022 Feb 27;2022:7222590. doi: 10.1155/2022/7222590. eCollection 2022. Biomed Res Int. 2022. PMID: 35265716 Free PMC article.
-
The Role of Oxidative Stress and Inflammation in the Pathogenesis and Treatment of Vascular Dementia.Cells. 2025 Apr 17;14(8):609. doi: 10.3390/cells14080609. Cells. 2025. PMID: 40277934 Free PMC article. Review.
-
Observation on the clinical efficacy of external ventricular drain combined with intraventricular urokinase injection and intravenous piracetam in the treatment of intraventricular hemorrhage.Pak J Med Sci. 2022 May-Jun;38(5):1292-1297. doi: 10.12669/pjms.38.5.4820. Pak J Med Sci. 2022. PMID: 35799762 Free PMC article.
References
-
- Miyamoto N., Tanaka R., Shimura H. et al. Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain. J. Cereb. Flow Metab. (2010) 30 299-310.
-
- Yanhong O., Chandra M., Venkatesh D. Mild cognitive impairment in adult: a neuropsychological review. Ann. Indian Acad. Neurol. (2013) 16 16310-16318.
-
- Gupta S., Sharma B. Pharmacological modulation of I 1-imidazoline and α 2-adrenoceptors in sub acute brain ischemia induced vascular dementia. Eur. J. Pharmacol. (2014) 723 72380-72390.
-
- Cervellati C., Romani A., Seripa D. et al. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia. J. Neurol. Sci. (2014) 337 156-161.
-
- Bennett S., Grant M.M., Aldred S. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. J. Alzheimers Dis. (2009) 17 245-257. https://doi.org/10.3233/JAD-2009-1041.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources